Key Points
- Dawn Christine Maroney, Alignment Healthcare president, sold 36,749 shares on March 18 at an average price of $17.84 for about $655,602, trimming her stake by ~3.35% to 1,058,813 shares.
- Several other senior insiders — including CEO John E. Kao (73,046 shares) and the COO — executed sizable sales on March 18, signaling coordinated/ broad insider selling that day.
- Separately, Alignment beat Q expectations with ($0.05) EPS vs. ($0.15) est and revenue of $1.01B (up 44.4% y/y); the company has a market cap of ~$3.71B and a consensus analyst price target of $24.56 (Moderate Buy).
Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) insider Robert Scavo sold 11,285 shares of the company's stock in a transaction dated Wednesday, March 18th. The shares were sold at an average price of $17.84, for a total transaction of $201,324.40. Following the completion of the transaction, the insider owned 487,685 shares in the company, valued at approximately $8,700,300.40. This trade represents a 2.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
Alignment Healthcare Stock Performance
Shares of NASDAQ ALHC opened at $17.96 on Friday. The company has a market cap of $3.67 billion, a PE ratio of -1,794.01, a price-to-earnings-growth ratio of 2.66 and a beta of 1.18. Alignment Healthcare, Inc. has a 12 month low of $11.63 and a 12 month high of $23.87. The company has a debt-to-equity ratio of 1.80, a current ratio of 1.71 and a quick ratio of 1.71. The company has a 50-day simple moving average of $20.51 and a 200-day simple moving average of $18.78.
Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its quarterly earnings data on Thursday, February 26th. The company reported ($0.05) earnings per share for the quarter, beating analysts' consensus estimates of ($0.15) by $0.10. The business had revenue of $1.01 billion during the quarter, compared to analyst estimates of $1 billion. Alignment Healthcare had a negative net margin of 0.02% and a negative return on equity of 0.49%. The company's revenue was up 44.4% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.16) earnings per share. On average, equities analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently commented on ALHC shares. TD Cowen lifted their price objective on Alignment Healthcare from $18.50 to $25.00 and gave the company a "buy" rating in a research report on Friday, January 16th. Robert W. Baird set a $28.00 target price on Alignment Healthcare in a research report on Friday, January 30th. JPMorgan Chase & Co. raised their price target on Alignment Healthcare from $23.00 to $26.00 and gave the stock an "overweight" rating in a research note on Thursday, February 5th. KeyCorp restated an "overweight" rating and issued a $28.00 price target on shares of Alignment Healthcare in a report on Thursday, January 22nd. Finally, Weiss Ratings reiterated a "sell (d-)" rating on shares of Alignment Healthcare in a report on Wednesday, January 21st. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $24.56.
Read Our Latest Stock Report on ALHC
Institutional Trading of Alignment Healthcare
Institutional investors and hedge funds have recently made changes to their positions in the company. Wellington Management Group LLP raised its position in shares of Alignment Healthcare by 167.3% in the 3rd quarter. Wellington Management Group LLP now owns 11,089,727 shares of the company's stock worth $193,516,000 after buying an additional 6,940,277 shares during the period. Invesco Ltd. grew its position in Alignment Healthcare by 122.3% during the second quarter. Invesco Ltd. now owns 4,170,529 shares of the company's stock valued at $58,387,000 after acquiring an additional 2,294,739 shares during the period. Capital World Investors acquired a new stake in Alignment Healthcare during the fourth quarter worth about $44,203,000. Loomis Sayles & Co. L P purchased a new position in shares of Alignment Healthcare in the 4th quarter worth about $44,162,000. Finally, Danica Pension Livsforsikringsaktieselskab purchased a new position in shares of Alignment Healthcare in the 4th quarter worth about $39,500,000. 86.19% of the stock is currently owned by institutional investors and hedge funds.
Alignment Healthcare News Summary
Here are the key news stories impacting Alignment Healthcare this week:
- Positive Sentiment: Analyst optimism — several brokerages have raised price targets and maintained Overweight/Buy views (Piper Sandler, KeyCorp, JPMorgan, Robert W. Baird), supporting upside expectations and a consensus "Moderate Buy" rating. MarketBeat ALHC Analyst Coverage
- Positive Sentiment: Recent earnings beat — Alignment reported Q4 revenue of ~$1.01B and EPS of ($0.05), topping consensus (revenue ~ $1.00B; EPS -$0.15), showing strong revenue growth (Y/Y +44%). This fundamental print remains supportive. Earnings Summary
- Neutral Sentiment: Zacks comparison piece — a valuation/comparison article contrasts ALHC with BrightSpring (BTSG); useful context for long-term investors but not an immediate market catalyst. BTSG or ALHC: Which Is the Better Value Stock Right Now?
- Neutral Sentiment: Reported short-interest data appears erroneous (shows 0 shares / NaN changes). Do not treat published short-interest figures as evidence of rising short pressure until exchanges correct the data.
- Negative Sentiment: CEO sale — John E. Kao sold 73,046 shares at an average $17.84 (~$1.30M), trimming his stake ~3.93%. This large insider sale is a near-term negative signal for sentiment. SEC Filing — Kao
- Negative Sentiment: Multiple senior insider sales on Mar 18 — President Dawn C. Maroney (36,749 shares, $17.84; also several prior sales in March/Jan), COO Sebastian Burzacchi (15,361 shares, $17.84), Christopher J. Joyce (25,125 shares, $17.84), Hyong Kim (18,404 shares, $17.84), Andreas P. Wagner (12,000 @ $17.84 and 11,602 @ $18.22), and Robert L. Scavo (11,285 shares, $17.84). These clustered disposals by senior management create headline risk and downward pressure. Representative filings: Maroney — Maroney SEC Filing; Joyce — Joyce SEC Filing; Wagner filings — Wagner SEC Filing
Alignment Healthcare Company Profile
(
Get Free Report)
Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.
At the core of Alignment Healthcare's approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
